GDF-15 is highly overexpressed in colorectal, ovarian, lung, and many other cancer types (Wischhusen et al., 2020), and is therefore considered a promising biomarker for cancer prognosis in addition to its potential role in cancer cell evasion of anti-tumor immune responses. The gene discussed is GDF15; the disease is cancer.